Insight Molecular Diagnostics (IMDX) Research & Development (2015 - 2026)

Insight Molecular Diagnostics has disclosed Research & Development across 12 years of filings, most recently posting $5.0 million for Q1 2026.

• Research & Development for Q1 2026 came in at $5.0 million, up 69.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.9 million (up 71.67% YoY), and the FY2025 annual result was $15.9 million, up 61.6% from the prior year.
• Research & Development came in at $5.0 million for Q1 2026 at Insight Molecular Diagnostics, down from $5.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $5.8 million in Q4 2025 to a low of $1.4 million in Q4 2022.
• The 5-year median for Research & Development is $2.4 million (2022), against an average of $2.8 million.
• Across the five-year window, Research & Development slumped 69.98% in 2022 and jumped 158.26% in 2025, its largest moves.
• Insight Molecular Diagnostics' Research & Development stood at $1.4 million in 2022, then surged by 84.83% to $2.5 million in 2023, then fell by 11.39% to $2.3 million in 2024, then jumped by 158.26% to $5.8 million in 2025, then slipped by 15.03% to $5.0 million in 2026.
• The last three Research & Development figures came in at $5.0 million (Q1 2026), $5.8 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.